CClinicalTrials.gg
CompletedNCT04179682Updated Nov 27, 2019

A Pilot Study of Constraint Induced Movement Therapy in Preschool Cerebral Palsy After Botulism Toxin Injection

An interventional study of 40-hour constraint-induced movement therapy in Cerebral Palsy, Spastic and Rehabilitation, sponsored by Changhua Christian Hospital. Completed. Open to participants aged 3 Years to 6 Years. Per ClinicalTrials.gov, last updated 2019-11-27.

Sponsored by Changhua Christian Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Randomized
Ages
3 Years to 6 Years
Sex
All
01

Study summary

To establish a pilot randomized, crossover study on applying 2 constraint-induced movement therapy (CIMT) interventions in children with hemiplegic cerebral palsy after botulinum toxin injection during preschool education.

Read the detailed description

This study was designed to be a pilot study on the use of 4-week 2-hours/day and 2-week 4-hours/day CIMT interventions in children with hemiplegic CP after a BoNT-A injection in preschool education, and compared the effects and psychological stress of CP children relative to the 2 CIMT programs.

02

Conditions studied

  • Cerebral Palsy, Spastic
  • Rehabilitation

Keywords

  • cerebral palsy
  • constraint-induced movement therapy
  • botulinum toxin
  • rehabilitation
  • occupational therapy
03

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

hemiplegic or quadriplegic CP children were under a regular rehabilitation program with BoNT-A injections. They were classified as Gross Motor Function Classification System level I and II, aged between 3 and 6 years old, with at least below average mentality, and were in mainstream preschool education; the extension of their hemiplegic wrist and metaphalangeal joint was greater than 10 degrees.

Exclusion criteria

Exclusion Criteria:

Children were excluded if they (a) could not understand or cooperate with the CIMT program, (b) had joint contracture of an upper limb, and (c) could not actively extend their hemiplegic wrist.

04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
6 participants (actual)

Study arms

  • Active comparator
    4-week 2-hours/day CIMT program

    a 4-week 2-hours/day constraint program, total 40 hours CIMT, in preschool education.

    Procedure: 40-hour constraint-induced movement therapy

  • Active comparator
    2-week 4-hours/day CIMT program

    one was a 2-week 4-hours/day constraint program, total 40 hours CIMT, in preschool education.

    Procedure: 40-hour constraint-induced movement therapy

Interventions

  • Procedure40-hour constraint-induced movement therapy

    Participants were randomly allocated to 1 of 2 CIMT programs (40 hours): a 2-week 4-hours/day CIMT program and a 4-week 2-hours/day CIMT program. One CIMT program was performed 1 month after a BoNT-A injection, and then the second program was implemented with the next injection.

05

What researchers measure

Primary outcomes

  1. change of Modified Ashworth Scale(MAS)

    change of spasticity, from 0 to 4, higher scores mean a worse outcome.

    Time frame: 1 month after Botox injection, shortly after CIMT intervention, 2 months after CIMT, and 4 months after CIMT

  2. change of Visual-motor integration in Peabody-Developmental Motor Scales(PDMSⅡ)

    hand function, from 0 to 144, higher scores mean a better outcome.

    Time frame: 1 month after Botox injection, shortly after CIMT intervention, 2 months after CIMT, and 4 months after CIMT

  3. Change of grasping in Peabody-Developmental Motor Scales(PDMSⅡ)

    hand function. from 0 to 52, higher scores mean a better outcome.

    Time frame: 1 month after Botox injection, shortly after CIMT intervention, 2 months after CIMT, and 4 months after CIMT

  4. Change of Chinese Version of Pediatric Evaluation of Disability Inventory( PEDI-C)

    ADL, from 0 to 73, higher scores mean a better outcome.

    Time frame: 1 month after Botox injection, shortly after CIMT intervention, 2 months after CIMT and 4 months after CIMT

  5. Change of GAS(goal attainment scale)

    GAS included 2 playing goals and 2 self-care goals.The goals were decided by the occupation therapist, the preschool teacher and the major caregiver. From (-2) to 2, higher scores mean a better outcome.

    Time frame: 1 month after Botox injection, 2 months after CIMT and 4 months after CIMT

  6. Change of Caregiver-Teacher Report Form (C-TRF)-Diagnostic scale of the Achenbach System of Empirically-Based Assessment (ASEBA)

    From 0 to 14, higher scores mean a worse outcome.

    Time frame: 1 month after Botox injection, shortly after CIMT intervention, 2 months after CIMT and 4 months after CIMT

  7. Change of Statistical Manual (DSM)-oriented scale of the Achenbach System of Empirically-Based Assessment (ASEBA)

    From 0 to 14, higher scores mean a worse outcome.

    Time frame: 1 month after Botox injection, shortly after CIMT intervention, 2 months after CIMT and 4 months after CIMT

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT04179682
Lead sponsor
Changhua Christian Hospital
Responsible party
Sponsor
First posted
Nov 27, 2019
Start date
Jul 1, 2014
Primary completion
Feb 10, 2019
Completion
Oct 1, 2019
Last update
Nov 27, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion